COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D PXPX FLVFLV PVP-IPI HC QHC Q BHBH CICI BLBL NZNZ COCO BUBU More..
Global ivermectin adoption for COVID-19: 33%
Share  
Download Image
Ivermectin is currently used for about 24% of the world's population. Countries where COVID-19 mortality is close to zero may not have incentive to adopt treatments. When excluding these countries, ivermectin adoption is about 33%. We excluded countries where the cumulative mortality over the preceding month was less than 1 in 1 million, according to the data at https://ourworldindata.org/). For the estimated population coverage, isolated use, some regions, mixed usage, and many regions use a factor of 0.05, 0.25, 0.5, and 0.75 respectively. Please send us corrections/updates with the form at the bottom of the page.
References
Argentina - mixed usage - Jan 26, 2021
Bangladesh - country-wide adoption
Belize - country-wide adoption - used for serious cases - Dec 18, 2020
Bolivia - country-wide adoption
Brazil - used in some regions - Jan 26, 2021
Bulgaria - country-wide adoption
Czech Republic - country-wide adoption
Dominican Republic - country-wide adoption - Sep 30, 2020
Egypt - country-wide adoption - Nov 30, 2020
El Salvador - country-wide adoption
Germany - isolated use - 12/31/2021
Guatemala - country-wide adoption - Jan 23, 2021
Honduras - country-wide adoption - 4/23/2020
India - used in many regions - used in many locations
Iran - used in some regions - now manufacturing their own ivermectin, but the level of usage is unclear
Japan - used in some regions - Feb 13, 2021
Lebanon - country-wide adoption - Jan 27, 2021
Mexico - used in some regions - Dec 29, 2020
Nicaragua - country-wide adoption - Jan 25, 2021
Nigeria - used in many regions
North Macedonia - mixed usage - Jan 15, 2021
Panama - country-wide adoption
Peru - used in some regions - was widely used but later restricted, a study shows 14x reduction in excess deaths when used and 13x increase when restricted - May 8, 2020
Philippines - isolated use
Portugal - used in some regions
Slovakia - mixed usage - while approved, press has been divided, censorship is common, and access is limited but improving - Jan 27, 2021
South Africa - mixed usage - may be prescribed without section 21 approval from 3/17/21, compounding allowed from 4/7/21 - Jan 27, 2021
USA - used in some regions - Oct 31, 2020
Venezuela - country-wide adoption
Zimbabwe - country-wide adoption - Jan 28, 2021
Please send us corrections, updates, or comments. Vaccines and treatments are both extremely valuable and complementary. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation.
Submit